Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches

Colorectal cancer (CRC) represents 10% of all cancer types, making it the third leading cause of cancer-related deaths globally. Metastasis is the primary factor causing mortality in CRC patients. Approximately 22% of CRC-related deaths have metastasis present at diagnosis, with approximately 70% of...

Description complète

Détails bibliographiques

Auteurs principaux:	Furong Li, Yanping Lin, Rong Li, Xin Shen, Mengying Xiang, Guangrui Xiong, Ke Zhang, Tingrong Xia, Jiangyan Guo, Zhonghui Miao, Yedan Liao, Xuan Zhang, Lin Xie
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2023-10-01
Collection:	Frontiers in Pharmacology
Sujets:	colorectal cancer molecular targeted therapy VEGF epidermal growth factor receptor RAS Her-2
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1165666/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!